LENSAR, Inc. 8-K

What Happened
LENSAR, Inc. (LNSR) filed a Form 8-K reporting that Chief Financial Officer Thomas R. Staab, II notified the company on April 10, 2026 that he will resign as CFO effective May 8, 2026 to pursue other professional opportunities. Mr. Staab will continue to serve as the company’s principal financial officer through the Transition Date. The filing states his resignation was not due to any disagreement with the company on operations, policies or practices.

Key Details

• Filing: Form 8-K filed April 15, 2026 reporting the change under Item 5.02 (departure of officers).
• Resignation notice date: April 10, 2026.
• Effective (Transition) date: May 8, 2026; Mr. Staab will remain in his role through that date.
• Company action: LENSAR has commenced a search for a new Chief Financial Officer.
• Signed by: Nicholas T. Curtis, Chief Executive Officer.

Why It Matters
A CFO departure is a material leadership change for a small-cap medical device company like LENSAR. The company has provided for an orderly transition (Mr. Staab remains through May 8) and has started a search for a successor. Investors should note the change in senior finance leadership and watch for further announcements about the CFO search and any interim arrangements or updates to financial reporting responsibilities.